Alan Berezov
- Oncology top 5%
- HER2/EGFR in Cancer Research 13
-
- Monoclonal and Polyclonal Antibodies Research 15
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 4
- Chemical Synthesis and Analysis 3
- Immunology top 10%
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 5
- Cell Biology top 10%
-
- NF-κB Signaling Pathways 4
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Ramachandran MuraliHongtao ZhangMark I. GreeneQiang WangGeng ZhangJeffrey A. DrebinPatrick J. BrennanEmi Suzuki
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Journal of Biological Chemistry (3 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Alan Berezov
33 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 97
- Oncology 721
- Radiology, Nuclear Medicine and Imaging 465
- Molecular Biology 1000
- Immunology 293
- Cell Biology 189
Countries citing papers authored by Alan Berezov
This map shows the geographic impact of Alan Berezov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Berezov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Berezov more than expected).
Fields of papers citing papers by Alan Berezov
This network shows the impact of papers produced by Alan Berezov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Berezov. The network helps show where Alan Berezov may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Berezov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 49 | |
| 2 | 2012 | 80 | |
| 3 | 2012 | 129 | |
| 4 | 2011 | 6 | |
| 5 | 2011 | 113 | |
| 6 | 2010 | 25 | |
| 7 | 2009 | 3 | |
| 8 | BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors. | 2008 | 105 |
| 9 | 2008 | 7 | |
| 10 | 2007 | 20 | |
| 11 | 2007 | 454 | |
| 12 | 2006 | 17 | |
| 13 | 2005 | 38 | |
| 14 | 2005 | 2 | |
| 15 | 2004 | 46 | |
| 16 | Antibody like peptidomimetics as large scale immunodetection probes. | 2003 | 3 |
| 17 | 2000 | 138 | |
| 18 | 2000 | 155 | |
| 19 | 1999 | 2 | |
| 20 | 1996 | 2 |
About Alan Berezov
Alan Berezov is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Clinical Biochemistry, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (13 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers), Glycosylation and Glycoproteins Research (4 papers), NF-κB Signaling Pathways (4 papers), Chemical Synthesis and Analysis (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Oncology (721 citations), Radiology, Nuclear Medicine and Imaging (465 citations) and Molecular Biology (1000 citations). Alan Berezov has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Ramachandran Murali, Hongtao Zhang, Mark I. Greene, Qiang Wang, Mark I. Greene, Geng Zhang, Jeffrey A. Drebin, Patrick J. Brennan, Emi Suzuki and Takako Mizuno. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.